Guyasuta Investment Advisors Inc. Has $4.27 Million Holdings in Colgate-Palmolive (NYSE:CL)

Guyasuta Investment Advisors Inc. decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 53,539 shares of the company’s stock after selling 568 shares during the quarter. Guyasuta Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $4,268,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. &PARTNERS increased its holdings in shares of Colgate-Palmolive by 0.7% in the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after purchasing an additional 129 shares during the period. West Branch Capital LLC increased its holdings in shares of Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the last quarter. First Foundation Advisors increased its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after purchasing an additional 136 shares during the last quarter. Waldron Private Wealth LLC increased its holdings in shares of Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares during the last quarter. Finally, Autumn Glory Partners LLC increased its stake in Colgate-Palmolive by 2.7% during the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock worth $424,000 after acquiring an additional 140 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.9 %

Shares of NYSE:CL traded down $0.78 during mid-day trading on Monday, reaching $90.23. 1,885,891 shares of the stock were exchanged, compared to its average volume of 4,575,406. The stock’s 50 day simple moving average is $87.66 and its 200-day simple moving average is $81.63. Colgate-Palmolive has a one year low of $67.62 and a one year high of $92.25. The company has a quick ratio of 0.28, a current ratio of 0.42 and a debt-to-equity ratio of 8.59. The company has a market cap of $74.17 billion, a P/E ratio of 28.67, a P/E/G ratio of 3.42 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the firm posted $0.73 earnings per share. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. As a group, equities research analysts predict that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Activity

In related news, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at approximately $24,161,117.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock valued at $19,505,099 over the last three months. Insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on CL shares. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. StockNews.com cut Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Barclays boosted their target price on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, April 12th. Morgan Stanley boosted their price target on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. Finally, Royal Bank of Canada upped their target price on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $91.13.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.